Altamira Therapeutics LTD. (CYTOF) — 20-F/A Filings
All 20-F/A filings from Altamira Therapeutics LTD.. Browse 2 20-F/A reports with AI-powered summaries and risk analysis.
20-F/A Filings (2)
-
Altamira Therapeutics Files 20-F/A Amendment
— Jul 1, 2024 Risk: low
Altamira Therapeutics Ltd. filed an amendment (No. 2) to its Form 20-F for the fiscal year ended December 31, 2023. This filing provides updated information and -
Altamira Therapeutics Ltd. Files Amendment to Annual Report
— Apr 22, 2024 Risk: low
Altamira Therapeutics Ltd. (CYTOF) filed a Amended Foreign Annual Report (20-F/A) with the SEC on April 22, 2024. Altamira Therapeutics Ltd. filed an amendment
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX